Taiwan FDA registration 1f4d417d71e3f012e4fbbc14d7f323f3

Recording of Paz G cancer antigen 15-3 test reagent standard

TW: 錄秘帕斯G癌抗原15-3檢驗試劑標準液

Taiwan·Risk Class 2·Fujirebio Inc. Sagamihara Facility·Registered Dec 14, 2010 – Dec 14, 2025Expired

Registration details

Analysis ID: 1f4d417d71e3f012e4fbbc14d7f323f3
Customs Code: DHA00602192605

Company information

Manufacturer: Fujirebio Inc. Sagamihara Facility
Manufacturer Country: Japan
Authorized Representative: Grand Marquis IVD CO., LTD.

Product details

Intended Use: Calibration reagent specially used to record the detection reagent of Paz G cancer antigen 15-3
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1150 Calibrated Products
Import Information: import

Dates and status

Registration Date: Dec 14, 2010
Expiry Date: Dec 14, 2025

About this record

Access comprehensive regulatory information for Recording of Paz G cancer antigen 15-3 test reagent standard in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1f4d417d71e3f012e4fbbc14d7f323f3 and manufactured by Fujirebio Inc. Sagamihara Facility. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.